"CHI Health Research Center at CUMC - Bergan is dedicated to delivering high quality, compassionate care to Omaha and nearby communities. Visit us at 7710 Mercy Rd or call (402) 343-8511 for more information."

During the past decade, CHI Health Research Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHI Health Research Center" #1 sponsor was "American Regent, Inc." with 1 trials, followed by "Astellas Pharma Global Development, Inc." with 1 trials sponsored, "C. R. Bard" with 1 trials sponsored, "Cerenis Therapeutics, SA" with 1 trials sponsored and "FoxHollow Technologies" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHI Health Research Center" #1 collaborator was "Boston Scientific Corporation" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Mylan GmbH" with 1 trials as a collaborator, "Nova Vascular LLC" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "CHI Health Research Center" are "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Aortic Valve Stenosis" (1 trials), "Atrial Fibrillation" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "CHI Health Research Center" in a lesser frequency.

Most popular intervention types in "CHI Health Research Center" are "Drug" (6 trials), "Device" (4 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ACE-I (lisinopril) or ARB (losartan)" (1 trials), "Adjustable Continence Therapy for Women (ACT)" (1 trials), "Aspirin" (1 trials) and "BuMA Supreme DES" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHI Health Research Center" are 9 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CHI Health Research Center". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in CHI Health Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in CHI Health Research Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".

CHI Health Research Center has several departments that took part in Clinical trials: "Alegant Health Cancer Center at Bergan Mercy Medical Center" - 84 trials, "Good Samaritan Cancer Center at Good Samaritan Hospital" - 64 trials, "Saint Francis Cancer Treatment Center" - 10 trials, "Saint Elizabeth Cancer Institute at Saint Elizabeth Regional Medical Center" - 3 trials